Benzylpiperazine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Benzylpiperazine
Systematic (IUPAC) name
1-benzylpiperazine
Identifiers
CAS number 2759-28-6
ATC code none
PubChem 75994
ChemSpider 68493
Chemical data
Formula C11H16N2 
Mol. mass 176.258 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability Unknown
Metabolism Hepatic
Half life 5.5 Hours [1]
Excretion Renal
Therapeutic considerations
Pregnancy cat.

?

Legal status

Schedule I(US) Legal in some countries

Routes Oral, intravenous, insufflation

Benzylpiperazine, commonly referred to as BZP is an recreational drug. It is also available with trade names such as "A2", "Frenzy" and "Nemesis",[2] It is a stimulant and may cause Euphoria. People believe it works in a way similar to MDMA. The effects produced by BZP are comparable to those produced by amphetamine. Side-effects include acute psychosis, problems with the kidneys Adverse effects have been reported following its use including acute psychosis and seizures. It does not appear to be very addictive and no deaths have been reported following taking BZP once. There have been at least two deaths which resulted from the combination of BZP and MDMA. Its sale is banned in a few countries, including the United States, Australia, New Zealand and in parts of Europe.[3] However, its legal status is currently less restrictive in some other countries such as Ireland and Canada. The European Union is currently changing its laws to regulate this substance more.

[change] References


Personal tools
Namespaces

Variants
Actions
Getting around
Print/export
Toolbox
In other languages